GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $353,000 | 0.0% | 9,735 | 0.0% | 0.03% | 0.0% |
| Q1 2021 | $353,000 | -6.4% | 9,735 | -3.0% | 0.03% | -12.1% |
| Q4 2020 | $377,000 | -39.4% | 10,035 | -38.5% | 0.03% | -38.9% |
| Q3 2020 | $622,000 | -7.6% | 16,304 | 0.0% | 0.05% | -16.9% |
| Q2 2020 | $673,000 | +4.2% | 16,304 | -2.9% | 0.06% | -13.3% |
| Q1 2020 | $646,000 | -19.0% | 16,798 | +0.0% | 0.08% | 0.0% |
| Q4 2019 | $798,000 | +7.0% | 16,793 | -2.9% | 0.08% | -2.6% |
| Q3 2019 | $746,000 | +6.6% | 17,289 | +0.0% | 0.08% | +4.1% |
| Q2 2019 | $700,000 | -2.8% | 17,284 | +1.8% | 0.07% | -7.5% |
| Q1 2019 | $720,000 | +13.0% | 16,978 | +3.1% | 0.08% | 0.0% |
| Q4 2018 | $637,000 | +0.6% | 16,473 | +5.7% | 0.08% | +17.6% |
| Q3 2018 | $633,000 | +2.1% | 15,578 | +2.6% | 0.07% | -2.9% |
| Q2 2018 | $620,000 | +4.0% | 15,188 | +1.3% | 0.07% | +1.4% |
| Q1 2018 | $596,000 | +0.7% | 14,988 | -10.1% | 0.07% | -1.4% |
| Q4 2017 | $592,000 | -19.7% | 16,678 | -8.1% | 0.07% | -23.1% |
| Q3 2017 | $737,000 | -4.8% | 18,153 | +1.1% | 0.09% | -7.1% |
| Q2 2017 | $774,000 | +1.4% | 17,953 | -0.8% | 0.10% | 0.0% |
| Q1 2017 | $763,000 | -36.9% | 18,103 | -42.4% | 0.10% | +18.1% |
| Q4 2016 | $1,210,000 | +38.9% | 31,406 | +55.5% | 0.08% | -35.2% |
| Q3 2016 | $871,000 | +0.9% | 20,203 | +1.5% | 0.13% | +0.8% |
| Q2 2016 | $863,000 | -1.0% | 19,903 | -7.4% | 0.13% | -3.1% |
| Q1 2016 | $872,000 | -9.1% | 21,503 | -9.6% | 0.13% | -7.1% |
| Q4 2015 | $959,000 | -36.0% | 23,778 | -39.0% | 0.14% | -40.5% |
| Q3 2015 | $1,499,000 | -10.8% | 38,978 | -3.3% | 0.24% | -9.2% |
| Q2 2015 | $1,680,000 | -10.0% | 40,328 | -0.3% | 0.26% | -7.4% |
| Q1 2015 | $1,867,000 | +25.6% | 40,453 | +16.2% | 0.28% | +23.1% |
| Q4 2014 | $1,487,000 | +5.7% | 34,803 | +13.7% | 0.23% | +2.2% |
| Q3 2014 | $1,407,000 | +8.7% | 30,603 | +26.4% | 0.22% | +9.3% |
| Q2 2014 | $1,294,000 | +105.7% | 24,203 | +105.5% | 0.20% | +95.2% |
| Q1 2014 | $629,000 | +24.3% | 11,778 | +24.3% | 0.10% | +23.5% |
| Q4 2013 | $506,000 | +517.1% | 9,478 | +294.9% | 0.08% | +304.8% |
| Q2 2010 | $82,000 | – | 2,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |